2-(adamantane-1-carbonyl)-N-hydroxy-1,3,4,5-tetrahydropyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-benzyl-N-hydroxy-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazine-7-carboxamide;5-[2-(4-chlorophenyl)-2-methylpropanoyl]-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;7-(2,2-dimethylpropanoyl)-N-hydroxy-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;5-(2,2-dimethylpropanoyl)-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;2-(3,5-dimethyl-1H-pyrrole-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-2-(1-methylpyrazole-3-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide

C104H130ClN27O21 — CID 162230485

IUPAC2-(adamantane-1-carbonyl)-N-hydroxy-1,3,4,5-tetrahydropyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-benzyl-N-hydroxy-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazine-7-carboxamide;5-[2-(4-chlorophenyl)-2-methylpropanoyl]-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;7-(2,2-dimethylpropanoyl)-N-hydroxy-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;5-(2,2-dimethylpropanoyl)-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;2-(3,5-dimethyl-1H-pyrrole-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-2-(1-methylpyrazole-3-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide
SMILESCC(C)(C(=O)N1CCn2nc(C(=O)NO)cc2C1)c1ccc(Cl)cc1.CC(C)(C)C(=O)N1CCn2cc(C(=O)NO)nc2C1.CC(C)(C)C(=O)N1CCn2nc(C(=O)NO)cc2C1.Cc1cc(C)c(C(=O)N2CCn3cc(C(=O)NO)cc3C2)[nH]1.Cn1ccc(C(=O)N2CCn3cc(C(=O)NO)cc3C2)n1.O=C(NO)c1cc2n(c1)CCCN(C(=O)C13CC4CC(CC(C4)C1)C3)C2.O=C(NO)c1cc2n(c1)CCN(Cc1ccccc1)C2=O
InChIInChI=1S/C20H27N3O3.C17H19ClN4O3.C15H18N4O3.C15H15N3O3.C13H15N5O3.2C12H18N4O3/c24-18(21-26)16-7-17-12-23(3-1-2-22(17)11-16)19(25)20-8-13-4-14(9-20)6-15(5-13)10-20;1-17(2,11-3-5-12(18)6-4-11)16(24)21-7-8-22-13(10-21)9-14(19-22)15(23)20-25;1-9-5-10(2)16-13(9)15(21)19-4-3-18-7-11(14(20)17-22)6-12(18)8-19;19-14(16-21)12-8-13-15(20)18(7-6-17(13)10-12)9-11-4-2-1-3-5-11;1-16-3-2-11(14-16)13(20)18-5-4-17-7-9(12(19)15-21)6-10(17)8-18;1-12(2,3)11(18)16-5-4-15-6-8(10(17)14-19)13-9(15)7-16;1-12(2,3)11(18)15-4-5-16-8(7-15)6-9(13-16)10(17)14-19/h7,11,13-15,26H,1-6,8-10,12H2,(H,21,24);3-6,9,25H,7-8,10H2,1-2H3,(H,20,23);5-7,16,22H,3-4,8H2,1-2H3,(H,17,20);1-5,8,10,21H,6-7,9H2,(H,16,19);2-3,6-7,21H,4-5,8H2,1H3,(H,15,19);2*6,19H,4-5,7H2,1-3H3,(H,14,17)
InChIKeyZVIVMFRJGVBXGK-UHFFFAOYSA-N
MW2129.80 g/mol
LogP7.78
Rot. Bonds14

About 2-(adamantane-1-carbonyl)-N-hydroxy-1,3,4,5-tetrahydropyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-benzyl-N-hydroxy-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazine-7-carboxamide;5-[2-(4-chlorophenyl)-2-methylpropanoyl]-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;7-(2,2-dimethylpropanoyl)-N-hydroxy-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;5-(2,2-dimethylpropanoyl)-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;2-(3,5-dimethyl-1H-pyrrole-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-2-(1-methylpyrazole-3-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide

2-(adamantane-1-carbonyl)-N-hydroxy-1,3,4,5-tetrahydropyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-benzyl-N-hydroxy-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazine-7-carboxamide;5-[2-(4-chlorophenyl)-2-methylpropanoyl]-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;7-(2,2-dimethylpropanoyl)-N-hydroxy-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;5-(2,2-dimethylpropanoyl)-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;2-(3,5-dimethyl-1H-pyrrole-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-2-(1-methylpyrazole-3-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide (PubChem CID 162230485) has the molecular formula C104H130ClN27O21 and a molecular weight of 2129.80 g/mol. Its IUPAC name is 2-(adamantane-1-carbonyl)-N-hydroxy-1,3,4,5-tetrahydropyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-benzyl-N-hydroxy-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazine-7-carboxamide;5-[2-(4-chlorophenyl)-2-methylpropanoyl]-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;7-(2,2-dimethylpropanoyl)-N-hydroxy-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;5-(2,2-dimethylpropanoyl)-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;2-(3,5-dimethyl-1H-pyrrole-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-2-(1-methylpyrazole-3-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide.

Molecular Properties

Compound Name2-(adamantane-1-carbonyl)-N-hydroxy-1,3,4,5-tetrahydropyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-benzyl-N-hydroxy-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazine-7-carboxamide;5-[2-(4-chlorophenyl)-2-methylpropanoyl]-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;7-(2,2-dimethylpropanoyl)-N-hydroxy-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;5-(2,2-dimethylpropanoyl)-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;2-(3,5-dimethyl-1H-pyrrole-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-2-(1-methylpyrazole-3-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide
PubChem CID162230485
Molecular FormulaC104H130ClN27O21
Molecular Weight2129.80 g/mol
Exact Mass2127.96
IUPAC Name2-(adamantane-1-carbonyl)-N-hydroxy-1,3,4,5-tetrahydropyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-benzyl-N-hydroxy-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazine-7-carboxamide;5-[2-(4-chlorophenyl)-2-methylpropanoyl]-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;7-(2,2-dimethylpropanoyl)-N-hydroxy-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;5-(2,2-dimethylpropanoyl)-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;2-(3,5-dimethyl-1H-pyrrole-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-2-(1-methylpyrazole-3-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide
SMILESCC(C)(C(=O)N1CCn2nc(C(=O)NO)cc2C1)c1ccc(Cl)cc1.CC(C)(C)C(=O)N1CCn2cc(C(=O)NO)nc2C1.CC(C)(C)C(=O)N1CCn2nc(C(=O)NO)cc2C1.Cc1cc(C)c(C(=O)N2CCn3cc(C(=O)NO)cc3C2)[nH]1.Cn1ccc(C(=O)N2CCn3cc(C(=O)NO)cc3C2)n1.O=C(NO)c1cc2n(c1)CCCN(C(=O)C13CC4CC(CC(C4)C1)C3)C2.O=C(NO)c1cc2n(c1)CCN(Cc1ccccc1)C2=O
InChIInChI=1S/C20H27N3O3.C17H19ClN4O3.C15H18N4O3.C15H15N3O3.C13H15N5O3.2C12H18N4O3/c24-18(21-26)16-7-17-12-23(3-1-2-22(17)11-16)19(25)20-8-13-4-14(9-20)6-15(5-13)10-20;1-17(2,11-3-5-12(18)6-4-11)16(24)21-7-8-22-13(10-21)9-14(19-22)15(23)20-25;1-9-5-10(2)16-13(9)15(21)19-4-3-18-7-11(14(20)17-22)6-12(18)8-19;19-14(16-21)12-8-13-15(20)18(7-6-17(13)10-12)9-11-4-2-1-3-5-11;1-16-3-2-11(14-16)13(20)18-5-4-17-7-9(12(19)15-21)6-10(17)8-18;1-12(2,3)11(18)16-5-4-15-6-8(10(17)14-19)13-9(15)7-16;1-12(2,3)11(18)15-4-5-16-8(7-15)6-9(13-16)10(17)14-19/h7,11,13-15,26H,1-6,8-10,12H2,(H,21,24);3-6,9,25H,7-8,10H2,1-2H3,(H,20,23);5-7,16,22H,3-4,8H2,1-2H3,(H,17,20);1-5,8,10,21H,6-7,9H2,(H,16,19);2-3,6-7,21H,4-5,8H2,1H3,(H,15,19);2*6,19H,4-5,7H2,1-3H3,(H,14,17)
InChIKeyZVIVMFRJGVBXGK-UHFFFAOYSA-N
XLogP7.78
TPSA594.27 Ų
H-Bond Donors15
H-Bond Acceptors33
Rotatable Bonds14
Heavy Atoms153
Complexity—

Lipinski Rule of Five

4 violations

RuleValue
MW ≤ 5002129.80
LogP ≤ 57.78
H-Bond Donors ≤ 515
H-Bond Acceptors ≤ 1033

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'hydroxamic_acid', 'substructure': 'N/A'}, {'alert_name': 'Oxygen-nitrogen_single_bond', 'substructure': 'N/A'}

Analyze 2-(adamantane-1-carbonyl)-N-hydroxy-1,3,4,5-tetrahydropyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-benzyl-N-hydroxy-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazine-7-carboxamide;5-[2-(4-chlorophenyl)-2-methylpropanoyl]-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;7-(2,2-dimethylpropanoyl)-N-hydroxy-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;5-(2,2-dimethylpropanoyl)-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;2-(3,5-dimethyl-1H-pyrrole-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-2-(1-methylpyrazole-3-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Frequently Asked Questions

What is the IUPAC name of 2-(adamantane-1-carbonyl)-N-hydroxy-1,3,4,5-tetrahydropyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-benzyl-N-hydroxy-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazine-7-carboxamide;5-[2-(4-chlorophenyl)-2-methylpropanoyl]-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;7-(2,2-dimethylpropanoyl)-N-hydroxy-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;5-(2,2-dimethylpropanoyl)-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;2-(3,5-dimethyl-1H-pyrrole-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-2-(1-methylpyrazole-3-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide?
The IUPAC name of 2-(adamantane-1-carbonyl)-N-hydroxy-1,3,4,5-tetrahydropyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-benzyl-N-hydroxy-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazine-7-carboxamide;5-[2-(4-chlorophenyl)-2-methylpropanoyl]-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;7-(2,2-dimethylpropanoyl)-N-hydroxy-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;5-(2,2-dimethylpropanoyl)-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;2-(3,5-dimethyl-1H-pyrrole-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-2-(1-methylpyrazole-3-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide (CID 162230485) is 2-(adamantane-1-carbonyl)-N-hydroxy-1,3,4,5-tetrahydropyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-benzyl-N-hydroxy-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazine-7-carboxamide;5-[2-(4-chlorophenyl)-2-methylpropanoyl]-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;7-(2,2-dimethylpropanoyl)-N-hydroxy-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;5-(2,2-dimethylpropanoyl)-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;2-(3,5-dimethyl-1H-pyrrole-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-2-(1-methylpyrazole-3-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide.
What is the SMILES notation for 2-(adamantane-1-carbonyl)-N-hydroxy-1,3,4,5-tetrahydropyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-benzyl-N-hydroxy-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazine-7-carboxamide;5-[2-(4-chlorophenyl)-2-methylpropanoyl]-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;7-(2,2-dimethylpropanoyl)-N-hydroxy-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;5-(2,2-dimethylpropanoyl)-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;2-(3,5-dimethyl-1H-pyrrole-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-2-(1-methylpyrazole-3-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide?
The canonical SMILES for 2-(adamantane-1-carbonyl)-N-hydroxy-1,3,4,5-tetrahydropyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-benzyl-N-hydroxy-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazine-7-carboxamide;5-[2-(4-chlorophenyl)-2-methylpropanoyl]-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;7-(2,2-dimethylpropanoyl)-N-hydroxy-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;5-(2,2-dimethylpropanoyl)-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;2-(3,5-dimethyl-1H-pyrrole-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-2-(1-methylpyrazole-3-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide is CC(C)(C(=O)N1CCn2nc(C(=O)NO)cc2C1)c1ccc(Cl)cc1.CC(C)(C)C(=O)N1CCn2cc(C(=O)NO)nc2C1.CC(C)(C)C(=O)N1CCn2nc(C(=O)NO)cc2C1.Cc1cc(C)c(C(=O)N2CCn3cc(C(=O)NO)cc3C2)[nH]1.Cn1ccc(C(=O)N2CCn3cc(C(=O)NO)cc3C2)n1.O=C(NO)c1cc2n(c1)CCCN(C(=O)C13CC4CC(CC(C4)C1)C3)C2.O=C(NO)c1cc2n(c1)CCN(Cc1ccccc1)C2=O.
What is the InChIKey of 2-(adamantane-1-carbonyl)-N-hydroxy-1,3,4,5-tetrahydropyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-benzyl-N-hydroxy-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazine-7-carboxamide;5-[2-(4-chlorophenyl)-2-methylpropanoyl]-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;7-(2,2-dimethylpropanoyl)-N-hydroxy-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;5-(2,2-dimethylpropanoyl)-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;2-(3,5-dimethyl-1H-pyrrole-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-2-(1-methylpyrazole-3-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide?
The InChIKey is ZVIVMFRJGVBXGK-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H27N3O3.C17H19ClN4O3.C15H18N4O3.C15H15N3O3.C13H15N5O3.2C12H18N4O3/c24-18(21-26)16-7-17-12-23(3-1-2-22(17)11-16)19(25)20-8-13-4-14(9-20)6-15(5-13)10-20;1-17(2,11-3-5-12(18)6-4-11)16(24)21-7-8-22-13(10-21)9-14(19-22)15(23)20-25;1-9-5-10(2)16-13(9)15(21)19-4-3-18-7-11(14(20)17-22)6-12(18)8-19;19-14(16-21)12-8-13-15(20)18(7-6-17(13)10-12)9-11-4-2-1-3-5-11;1-16-3-2-11(14-16)13(20)18-5-4-17-7-9(12(19)15-21)6-10(17)8-18;1-12(2,3)11(18)16-5-4-15-6-8(10(17)14-19)13-9(15)7-16;1-12(2,3)11(18)15-4-5-16-8(7-15)6-9(13-16)10(17)14-19/h7,11,13-15,26H,1-6,8-10,12H2,(H,21,24);3-6,9,25H,7-8,10H2,1-2H3,(H,20,23);5-7,16,22H,3-4,8H2,1-2H3,(H,17,20);1-5,8,10,21H,6-7,9H2,(H,16,19);2-3,6-7,21H,4-5,8H2,1H3,(H,15,19);2*6,19H,4-5,7H2,1-3H3,(H,14,17).
What are the key properties of 2-(adamantane-1-carbonyl)-N-hydroxy-1,3,4,5-tetrahydropyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-benzyl-N-hydroxy-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazine-7-carboxamide;5-[2-(4-chlorophenyl)-2-methylpropanoyl]-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;7-(2,2-dimethylpropanoyl)-N-hydroxy-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;5-(2,2-dimethylpropanoyl)-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;2-(3,5-dimethyl-1H-pyrrole-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-2-(1-methylpyrazole-3-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide?
2-(adamantane-1-carbonyl)-N-hydroxy-1,3,4,5-tetrahydropyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-benzyl-N-hydroxy-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazine-7-carboxamide;5-[2-(4-chlorophenyl)-2-methylpropanoyl]-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;7-(2,2-dimethylpropanoyl)-N-hydroxy-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;5-(2,2-dimethylpropanoyl)-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;2-(3,5-dimethyl-1H-pyrrole-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-2-(1-methylpyrazole-3-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide has a molecular weight of 2129.80 g/mol, XLogP of 7.78, 14 rotatable bonds, 15 hydrogen bond donors, and 33 hydrogen bond acceptors.
Where does this data come from?
All data for 2-(adamantane-1-carbonyl)-N-hydroxy-1,3,4,5-tetrahydropyrrolo[1,2-a][1,4]diazepine-8-carboxamide;2-benzyl-N-hydroxy-1-oxo-3,4-dihydropyrrolo[1,2-a]pyrazine-7-carboxamide;5-[2-(4-chlorophenyl)-2-methylpropanoyl]-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;7-(2,2-dimethylpropanoyl)-N-hydroxy-6,8-dihydro-5H-imidazo[1,2-a]pyrazine-2-carboxamide;5-(2,2-dimethylpropanoyl)-N-hydroxy-6,7-dihydro-4H-pyrazolo[1,5-a]pyrazine-2-carboxamide;2-(3,5-dimethyl-1H-pyrrole-2-carbonyl)-N-hydroxy-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide;N-hydroxy-2-(1-methylpyrazole-3-carbonyl)-3,4-dihydro-1H-pyrrolo[1,2-a]pyrazine-7-carboxamide is sourced from PubChem (CID 162230485), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).